Cargando…

Editorial: Are natural products, used as antitumoral/antiangiogenic agents, less toxic than synthetic conventional chemotherapy?

Detalles Bibliográficos
Autores principales:	Nunez, Cecilia Veronica, de Vasconcellos, Marne Carvalho, Alaniz, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634553/ https://www.ncbi.nlm.nih.gov/pubmed/36339558 http://dx.doi.org/10.3389/fphar.2022.1055516

Ejemplares similares

Antiangiogenic Compound Axitinib Demonstrates Low Toxicity and Antitumoral Effects against Medulloblastoma
por: Pagnuzzi-Boncompagni, Marina, et al.
Publicado: (2021)

Antiangiogenic and Antitumor Effects of Trypanosoma cruzi Calreticulin
por: López, Nandy C., et al.
Publicado: (2010)

Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models
por: Harris, Emily M., et al.
Publicado: (2018)

Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
por: Esteruelas, Gerard, et al.
Publicado: (2022)

Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid
por: Ceci, Claudia, et al.
Publicado: (2018)

Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
por: Yoysungnoen-Chintana, Pornphrom, et al.
Publicado: (2014)

Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin
por: Huang, Xiao-Ping, et al.
Publicado: (2017)

Photodynamic therapy – hypericin tetraether liposome conjugates and their antitumor and antiangiogenic activity
por: Plenagl, Nikola, et al.
Publicado: (2019)

The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
por: Zhou, Ling, et al.
Publicado: (2023)

Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli
por: Setrerrahmane, Sarra, et al.
Publicado: (2017)

Are Green Household Consumer Products Less Toxic than Conventional Products? An Assessment Involving Grass Shrimp (Palaemon pugio) and Daphnia magna
por: Gray, Austin D., et al.
Publicado: (2022)

The combination of cantharidin and antiangiogenic therapeutics presents additive antitumor effects against pancreatic cancer
por: Xu, Meng-Dan, et al.
Publicado: (2018)

Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?
por: Gao, Xin, et al.
Publicado: (2019)

Antitumor and antiangiogenic activity of the novel chimeric inhibitor animacroxam in testicular germ cell cancer
por: Steinemann, Gustav, et al.
Publicado: (2019)

P32-specific CAR T cells with dual antitumor and antiangiogenic therapeutic potential in gliomas
por: Rousso-Noori, Liat, et al.
Publicado: (2021)

Do CAD/CAM dentures really release less monomer than conventional dentures?
por: Steinmassl, Patricia-Anca, et al.
Publicado: (2016)

Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity
por: Shim, Man Kyu, et al.
Publicado: (2022)

Bisphenol S is a haemodialysis-associated xenobiotic that is less toxic than bisphenol A
por: Mas, Sebastian, et al.
Publicado: (2020)

Chemotherapeutic potentials of the stem bark of Balanite aegyptiaca (L.) Delile: an antiangiogenic, antitumor and antioxidant agent
por: Hassan, Loiy E. Ahmed, et al.
Publicado: (2016)

Polydopamine-coated gold nanostar for combined antitumor and antiangiogenic therapy in multidrug-resistant breast cancer
por: You, You-Hong, et al.
Publicado: (2019)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
por: Rovithi, Maria, et al.
Publicado: (2017)

Improving antitumor immunity using antiangiogenic agents: Mechanistic insights, current progress, and clinical challenges
por: Li, Shu‐Jin, et al.
Publicado: (2021)

Intraductal Pancreatic Cancer is Less Responsive Than Cancer in the Stroma to Neoadjuvant Chemotherapy
por: Fujikura, Kohei, et al.
Publicado: (2020)

Minimal Lateral Internal Sphincterotomy (LIS): Is It Enough to Cut Less Than the Conventional Tailored LIS?
por: Lee, Keun-Hee, et al.
Publicado: (2021)

Laparoscopic liver resection is associated with less significant muscle loss than the conventional open approach
por: Gau, Ruoh-Yun, et al.
Publicado: (2022)

Radioprotective and tumor antiangiogenic effect of the novel synthetic superoxide dismutase (SOD) mimetic compounds
por: Vujaskovic, Z, et al.
Publicado: (2001)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Immune checkpoint inhibitor monotherapy is associated with less cardiac toxicity than combination therapy
por: Cone, Eugene B., et al.
Publicado: (2022)

Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy
por: Raica, Marius, et al.
Publicado: (2010)

CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
por: Devapatla, Bharat, et al.
Publicado: (2015)

Antitumor, Immunomodulatory and Antiangiogenic Efficacy of Medicinal Mushroom Extract Mixtures in Advanced Colorectal Cancer Animal Model
por: Jakopovic, Boris, et al.
Publicado: (2020)

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
por: Zhu, Yuxuan, et al.
Publicado: (2019)

Conjugation of VEGFR1/R2-targeting peptide with gold nanoparticles to enhance antiangiogenic and antitumoral activity
por: Zanjanchi, Pegah, et al.
Publicado: (2022)

Stability and Antioxidant Activity of Semi-synthetic Derivatives of 4-Nerolidylcatechol
por: Lima, Emerson Silva, et al.
Publicado: (2012)

Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxicities
por: Cohen, Roger B., et al.
Publicado: (2012)

In vivo stabilization of a less toxic asparaginase variant leads to a durable antitumor response in acute leukemia
por: Van Trimpont, Maaike, et al.
Publicado: (2022)

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib
por: Bocci, G, et al.
Publicado: (2008)

Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma
por: Vo, Kieuhoa T., et al.
Publicado: (2016)

Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
por: Yonucu, Sirin, et al.
Publicado: (2017)

Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells
por: Winter, Ursula, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3mr7e1dslj1b045aj6k440kps7